Fundus Changes in the Microphthalmy Eyes

Status Completed

Clinical Trial Summary

The goal is to describe the fundamental aspects of fundoscopic eye in patients with microphthalmia

Clinical Trial Description

Microphthalmos is a developmental ocular disorder defined as a small eyeball. The condition can be associated with abnormalities of anterior and posterior segments. The most common anterior characteristics include corneal opacities, angle-closure and a shallow anterior chamber and cataract. The main findings of posterior segment are uveal effusion, retinal folds, abnormalities of macular capillary vascularization, absence of foveal depression and peripheral retinoschisis. We performed on 3 patients with microphthalmos and their OCT features of posterior segment. ;

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00811512
Study type	Observational
Source	Hospital de Olhos Sadalla Amin Ghanem
Contact
Status	Completed
Phase	N/A
Start date	May 2007
Completion date	October 2008

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03872479` - Single Ascending Dose Study in Participants With LCA10	Phase 1/Phase 2
Active, not recruiting	`NCT04123626` - A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene	Phase 1/Phase 2
Completed	`NCT01727973` - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy	Phase 1/Phase 2
Completed	`NCT02946879` - Long-Term Follow-Up Gene Therapy Study for Leber Congenital Amaurosis OPTIRPE65 (Retinal Dystrophy Associated With Defects in RPE65)
Terminated	`NCT03913130` - Extension Study to Study PQ-110-001 (NCT03140969)	Phase 1/Phase 2
Completed	`NCT03780257` - Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene	Phase 1/Phase 2
Active, not recruiting	`NCT04765345` - Rate of Progression of PCDH15-Related Retinal Degeneration in Usher Syndrome 1F
Recruiting	`NCT05573984` - Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Recruiting	`NCT02203682` - Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy	Phase 2
Completed	`NCT04945772` - Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]	Phase 2
Enrolling by invitation	`NCT06162585` - Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
Active, not recruiting	`NCT05158296` - Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)	Phase 2/Phase 3
Completed	`NCT03396042` - Natural History Study of CEP290-Related Retinal Degeneration
Terminated	`NCT05176717` - Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)	Phase 2/Phase 3
Active, not recruiting	`NCT03913143` - A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)	Phase 2/Phase 3